These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3908169)

  • 21. Alopecia areata. Autoreactive T cells are variably enriched in scalp lesions relative to peripheral blood.
    Kalish RS; Johnson KL; Hordinsky MK
    Arch Dermatol; 1992 Aug; 128(8):1072-7. PubMed ID: 1497361
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Imbalance of T-helper 17 and regulatory T cells in patients with alopecia areata.
    Han YM; Sheng YY; Xu F; Qi SS; Liu XJ; Hu RM; Miao Y; Huang GQ; Yang QP
    J Dermatol; 2015 Oct; 42(10):981-8. PubMed ID: 26077574
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Topical immunotherapy changes the composition of the peribulbar infiltrate in alopecia areata.
    Happle R; Klein HM; Macher E
    Arch Dermatol Res; 1986; 278(3):214-8. PubMed ID: 2873796
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Apoptosis resistance in peripheral blood lymphocytes of alopecia areata patients.
    Zöller M; McElwee KJ; Vitacolonna M; Hoffmann R
    J Autoimmun; 2004 Nov; 23(3):241-56. PubMed ID: 15501395
    [TBL] [Abstract][Full Text] [Related]  

  • 25. T cell subpopulations and their functions in vitro. A study in patients with alopecia areata and alopecia universalis.
    Gu SQ; Ros AM; von Stedingk LV; Thyresson N; Wasserman J
    Int Arch Allergy Appl Immunol; 1981; 66(2):208-17. PubMed ID: 6974701
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autoimmune hair loss (alopecia areata) transferred by T lymphocytes to human scalp explants on SCID mice.
    Gilhar A; Ullmann Y; Berkutzki T; Assy B; Kalish RS
    J Clin Invest; 1998 Jan; 101(1):62-7. PubMed ID: 9421466
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blood lymphocyte subpopulations and antibody dependent, cell-mediated cytotoxicity (ADCC) in alopecia areata and universalis.
    Gu SQ; Ros AM; Thyresson N; Wasserman J
    Acta Derm Venereol; 1981; 61(2):125-9. PubMed ID: 6165187
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circulating lymphocyte subsets in patients with alopecia areata.
    Baadsgaard O; Lindskov R
    Acta Derm Venereol; 1986; 66(3):266-8. PubMed ID: 2426908
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Type 1 interferon signature in the scalp lesions of alopecia areata.
    Ghoreishi M; Martinka M; Dutz JP
    Br J Dermatol; 2010 Jul; 163(1):57-62. PubMed ID: 20346028
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Lymphocyte subpopulations in alopecia areata].
    Calandria L; Paciel J; Bruno J; Martini M; Vignale R; Civila E
    Med Cutan Ibero Lat Am; 1986; 14(3):163-5. PubMed ID: 3526043
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Response to minoxidil in severe alopecia areata correlates with T lymphocyte stimulation.
    Fiedler-Weiss VC; Buys CM
    Br J Dermatol; 1987 Dec; 117(6):759-63. PubMed ID: 3501310
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Significance of HLA-DR+ T cells and natural killer (NK) cells in the peripheral blood lymphocytes of alopecia areata (AA)].
    Imai R
    Nihon Hifuka Gakkai Zasshi; 1990 Oct; 100(11):1143-52. PubMed ID: 2273577
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alopecia areata: infiltration of Th17 cells in the dermis, particularly around hair follicles.
    Tanemura A; Oiso N; Nakano M; Itoi S; Kawada A; Katayama I
    Dermatology; 2013; 226(4):333-6. PubMed ID: 23838575
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical and immunologic response to Isoprinosine in alopecia areata and alopecia universalis: association with autoantibodies.
    Lowy M; Ledoux-Corbusier M; Achten G; Wybran J
    J Am Acad Dermatol; 1985 Jan; 12(1 Pt 1):78-84. PubMed ID: 2579988
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in distribution pattern of CD8 lymphocytes in the scalp in alopecia areata during treatment with diphencyprone.
    Wasyłyszyn T; Kozłowski W; Zabielski SL
    Arch Dermatol Res; 2007 Aug; 299(5-6):231-7. PubMed ID: 17530266
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Correlation of activated T cells and natural killer (NK) cells with the disease activity of alopecia areata (AA)].
    Imai R; Miura J; Takamori K
    Nihon Hifuka Gakkai Zasshi; 1989 May; 99(6):743-5. PubMed ID: 2585776
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mediation of alopecia areata by cooperation between CD4+ and CD8+ T lymphocytes: transfer to human scalp explants on Prkdc(scid) mice.
    Gilhar A; Landau M; Assy B; Shalaginov R; Serafimovich S; Kalish RS
    Arch Dermatol; 2002 Jul; 138(7):916-22. PubMed ID: 12071819
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunotherapy of alopecia areata.
    Van Neste D; De Bruyère M; Breuillard F
    Arch Dermatol Res; 1979 Nov; 266(3):323-325. PubMed ID: 316690
    [No Abstract]   [Full Text] [Related]  

  • 39. Expression of vascular endothelial growth factor, apoptosis inhibitors (survivin and p16) and CCL27 in alopecia areata before and after diphencyprone treatment: an immunohistochemical study.
    Simonetti O; Lucarini G; Bernardini ML; Simoncini C; Biagini G; Offidani A
    Br J Dermatol; 2004 May; 150(5):940-8. PubMed ID: 15149507
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of the expression of cutaneous lymphocyte-associated antigen on the peripheral blood and cutaneous lymphocytes of alopecia areata patients.
    Yano S; Nakamura K; Okochi H; Tamaki K
    Acta Derm Venereol; 2002; 82(2):82-5. PubMed ID: 12125957
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.